| abstract |
FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to compounds of the formula (1): n and their salts wherein ring A comprises optionally heteroatom oxygen (O); dotted lines represent the optional unsaturation; R 1 represents (C 1 -C 4 )-alkoxy-group; R 2 and R 3 represent independently hydrogen atom (H), optionally halogenated (C 1 -C 4 )-alkyl, optionally substituted aromatic group, or R 2 and R 3 in common can form substituted or unsubstituted 5-7-membered ring condensed with ring E; k = 0-4; L 1 represents a covalent bond or (C 1 -C 6 )-alkyl optionally comprising nitrogen atom (N); X represents unsubstituted or substituted carbon © atom or N, or represents O or sulfur (S) atom; Ar represents phenylene; each n = 0-2 independently; each R represents independently H or (C 1 -C 6 )-alkyl; Y represents optionally substituted aromatic or heteroaromatic group or 5-11-membered heterocyclic group comprising 1-4 heteroatoms cgosen from N, O and S that are bound with chemokine receptors comprising CXCR4 and CCR5, and elicit the protective affect against damage of host-cells by human immunodeficiency virus (HIV). n EFFECT: valuable medicinal properties of compounds and pharmaceutical composition. |